Irreversible changes in protein conformation due to interaction with superparamagnetic iron oxide nanoparticles.

The understanding of the interactions between nanomaterials and proteins is of extreme importance in medicine. In a biological fluid, proteins can adsorb and associate with nanoparticles, which can have significant impact on the biological behavior of the proteins and the nanoparticles. We report here on the interactions of iron saturated human transferrin protein with both bare and polyvinyl alcohol coated superparamagnetic iron oxide nanoparticles (SPIONs). The exposure of human transferrin to SPIONs results in the release of iron, which changes the main function of the protein, which is the transport of iron among cells. After removal of the magnetic nanoparticles, the original protein conformation is not recovered, indicating irreversible changes in transferrin conformation: from a compact to an open structure.

[1]  E. Baker,et al.  New perspectives on the structure and function of transferrins. , 1992, Journal of inorganic biochemistry.

[2]  Morteza Mahmoudi,et al.  Optimal design and characterization of superparamagnetic iron oxide nanoparticles coated with polyvinyl alcohol for targeted delivery and imaging. , 2008, The journal of physical chemistry. B.

[3]  C. Carrano,et al.  Affinity labels for the anion-binding site in ovotransferrin. , 1988, Biochemistry.

[4]  Morteza Mahmoudi,et al.  A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles. , 2010, Colloids and surfaces. B, Biointerfaces.

[5]  J. Friedman,et al.  Binding and release of iron by gel-encapsulated human transferrin: Evidence for a conformational search , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Sara Linse,et al.  Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[7]  T. Xia,et al.  Toxic Potential of Materials at the Nanolevel , 2006, Science.

[8]  M. Mahmoudi,et al.  Superparamagnetic Iron Oxide Nanoparticles with Rigid Cross-linked Polyethylene Glycol Fumarate Coating for Application in Imaging and Drug Delivery , 2009 .

[9]  Y. Wang.  Nonlinear optical properties of nanometer-sized semiconductor clusters , 1991 .

[10]  Louis E. Brus,et al.  Semiconductor crystallites: a class of large molecules , 1990 .

[11]  J. Santamaría,et al.  Magnetic nanoparticles for drug delivery , 2007 .

[12]  Louis E. Brus,et al.  Luminescence Photophysics in Semiconductor Nanocrystals , 1999 .

[13]  Iseult Lynch,et al.  What the cell "sees" in bionanoscience. , 2010, Journal of the American Chemical Society.

[14]  D. Rice,et al.  Structure of human lactoferrin: crystallographic structure analysis and refinement at 2.8 A resolution. , 1989, Journal of molecular biology.

[15]  V. Colvin.  The potential environmental impact of engineered nanomaterials , 2003, Nature Biotechnology.

[16]  Iseult Lynch,et al.  Protein-nanoparticle interactions: What does the cell see? , 2009, Nature nanotechnology.

[17]  H. Baker,et al.  Anion binding by human lactoferrin: results from crystallographic and physicochemical studies. , 1992, Biochemistry.

[18]  David B Warheit,et al.  Pulmonary instillation studies with nanoscale TiO2 rods and dots in rats: toxicity is not dependent upon particle size and surface area. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[19]  Jing Sun,et al.  Synthesis and characterization of biocompatible Fe3O4 nanoparticles. , 2007, Journal of biomedical materials research. Part A.

[20]  A. Alivisatos.  Semiconductor Clusters, Nanocrystals, and Quantum Dots , 1996, Science.

[21]  H. Baker,et al.  Structure of human lactoferrin at 3.2-A resolution. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Morteza Mahmoudi,et al.  An in vitro study of bare and poly(ethylene glycol)-co-fumarate-coated superparamagnetic iron oxide nanoparticles: a new toxicity identification procedure , 2009, Nanotechnology.

[23]  T. Faunce.  Integrated Research into the Nanoparticle-Protein Corona: A New Focus for Safe, Sustainable and Equitable Development of Nanomedicines , 2008, Nanomedicine.

[24]  Wolfgang J Parak,et al.  A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. , 2009, Nature nanotechnology.

[25]  H. Hofmann,et al.  Particle size investigations of a multistep synthesis of PVA coated superparamagnetic nanoparticles. , 2004, Journal of Colloid and Interface Science.

[26]  H. Hofmann,et al.  Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system , 2005 .

[27]  Kenneth A. Dawson,et al.  Nanotoxicology: nanoparticles reconstruct lipids. , 2009, Nature nanotechnology.

[28]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[29]  C. Ricolleau,et al.  Size and shape effects on the order-disorder phase transition in CoPt nanoparticles. , 2009, Nature materials.

[30]  M. Mahmoudi,et al.  Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. , 2011, Advanced drug delivery reviews.

[31]  James L. McGrath,et al.  The influence of protein adsorption on nanoparticle association with cultured endothelial cells. , 2009, Biomaterials.

[32]  Sara Linse,et al.  The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. , 2007, Advances in colloid and interface science.

[33]  K. Dawson,et al.  Detecting Cryptic Epitopes Created by Nanoparticles , 2006, Science's STKE.

[34]  J. G. Grossmann,et al.  Metal-induced conformational changes in transferrins. , 1993, Journal of molecular biology.

[35]  Jack F Douglas,et al.  Interaction of gold nanoparticles with common human blood proteins. , 2010, ACS nano.

[36]  Sara Linse,et al.  Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. , 2007, Angewandte Chemie.

[37]  Kenneth A. Dawson,et al.  Protein–Nanoparticle Interactions , 2008, Nano-Enabled Medical Applications.

[38]  U. Seal,et al.  The detection of four molecular forms of human transferrin during the iron binding process. , 1976, Biochimica et biophysica acta.

[39]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[40]  C. Carrano,et al.  The origin of the visible absorption in metal transferrins , 1981 .

[41]  M. Mahmoudi,et al.  Cytotoxicity of Uncoated and Polyvinyl Alcohol Coated Superparamagnetic Iron Oxide Nanoparticles , 2009 .

[42]  T. Xia,et al.  Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.

[43]  K. Metze,et al.  Structural and morphological investigation of magnetic nanoparticles based on iron oxides for biomedical applications , 2008 .

[44]  P Stroeve,et al.  Cell toxicity of superparamagnetic iron oxide nanoparticles. , 2009, Journal of colloid and interface science.

[45]  S. Nie,et al.  Quantum dot bioconjugates for ultrasensitive nonisotopic detection. , 1998, Science.